News
http://www.cysticfibrosis.ca/wp-content/themes/Cystic-Fibrosis-Canada/img/FB_Share_Image.jpg
DONATECLOSE
GENERAL DONATIONS
MONTHLY
IN HONOUR
IN MEMORY
NEWS AND MEDIA
Stay UP TO DATE on the latest news, announcements
and reports regarding cystic fibrosis in Canada

FEATURED NEWS

This past year, ten inspiring Kinsmen and Kinettes dedicated hundreds of hours to raising funds and awareness for Cystic Fibrosis Canada by motivating their fellow Kin members to take action in the fight against cystic fibrosis. Cystic Fibrosis…Read More
Posted on July 13, 2014 We are pleased to share news with you that cystic fibrosis patients ages six and above in Alberta with the G551D mutation will now have access to Kalydeco. Kalydeco is now listed on the Albert Drug Benefit List. Please…Read More
Posted by Ken Chan, Vice President, Advocacy, Research and Healthcare on June 27, 2014 Health Canada has approved Kalydeco for use by people with cystic fibrosis ages 6 and older who have one of ten mutations in the gene that causes cystic…Read More
Posted by Ken Chan, Vice President of Advocacy, Research and Healthcare on June 24, 2014 Vertex announced this morning that the Phase 3 clinical studies of ivacaftor (Kalydeco) in combination with lumacaftor (VX-809) for people with two copies of…Read More
Posted on June 20, 2014 at 4:15 pm We are pleased to share news with you that cystic fibrosis patients in Ontario with the G551D mutation now have access to Kalydeco through the Ontario Public Drug Program. Kalydeco is now listed on the Ontario…Read More
SHARE THIS PAGE